相关实验视频

Updated: Jun 4, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K

对Enoxaparin酸盐抗因子IIa强度的测定方法的验证研究

Xiaorong Yang1, Hanyan Zou1, Yixue Dong1

  • 1Chongqing Institute for Food and Drug Control, Chongqing, China.

PeerJ
|December 23, 2024
PubMed
概括

一个新的对氧沙的验证试验提高了测试可重复性. 这种方法提高了低分子量肝素 (LMMH) 药物的质量控制和药物安全.

关键词:
抗因子IIa 抗因子伊诺克萨帕林酸盐方法验证方法的验证方法.制药品质量控制 制药品质量控制强度测试试验 强度测试试验

更多相关视频

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.8K

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608